Developing a prediction model for adjuvant immunotherapy post-chemoradiation in stage III inoperable non-small-cell lung cancer

Clinical and Translational Radiation Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles